Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Anticoagulant Reversal Drugs Market, by Region, 2018-2026 (USD Million)
1.2.2. Anticoagulant Reversal Drugs Market, by Drug Class, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anticoagulant Reversal Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anticoagulant Reversal Drugs Market Dynamics
3.1. Anticoagulant Reversal Drugs Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Anticoagulant Reversal Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anticoagulant Reversal Drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Anticoagulant Reversal Drugs Market by Drug Class, Performance - Potential Analysis
5.3. Global Anticoagulant Reversal Drugs Market Estimates & Forecasts by Drug Class 2016-2026 (USD Million)
5.4. Anticoagulant Reversal Drugs Market, Sub Segment Analysis
5.4.1. Prothrombin Complex Concentrates
5.4.2. Coagulation Factors
5.4.3. Monoclonal Antibodies
5.4.4. Phytonadione
5.4.5. Others
Chapter 6. Global Anticoagulant Reversal Drugs Market, Regional Analysis
6.1. Anticoagulant Reversal Drugs Market, Regional Market Snapshot
6.2. North America Anticoagulant Reversal Drugs Market
6.2.1. U.S. Anticoagulant Reversal Drugs Market
6.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
6.2.2. Canada Anticoagulant Reversal Drugs Market
6.3. Europe Anticoagulant Reversal Drugs Market Snapshot
6.3.1. U.K. Anticoagulant Reversal Drugs Market
6.3.2. Germany Anticoagulant Reversal Drugs Market
6.3.3. Rest of Europe Anticoagulant Reversal Drugs Market
6.4. Asia-Pacific Anticoagulant Reversal Drugs Market Snapshot
6.4.1. China Anticoagulant Reversal Drugs Market
6.4.2. India Anticoagulant Reversal Drugs Market
6.4.3. Japan Anticoagulant Reversal Drugs Market
6.4.4. Rest of Asia Pacific Anticoagulant Reversal Drugs Market
6.5. Latin America Anticoagulant Reversal Drugs Market Snapshot
6.5.1. Brazil Anticoagulant Reversal Drugs Market
6.5.2. Mexico Anticoagulant Reversal Drugs Market
6.6. Rest of The World Anticoagulant Reversal Drugs Market

Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Portola Pharmaceuticals, Inc.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Boehringer Ingelheim GmbH
7.2.3. CSL Behring Limited
7.2.4. Pfizer Inc
7.2.5. Octapharma AG
7.2.6. Bausch Health Companies, Inc.
7.2.7. Amneal Pharmaceuticals Inc
7.2.8. Fresenius Kabi AG
7.2.9. Perosphere Pharmaceuticals Inc
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption



List of Figures


FIG 1. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA ANTICOAGULANT REVERSAL DRUGS MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE ANTICOAGULANT REVERSAL DRUGS MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC ANTICOAGULANT REVERSAL DRUGS MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA ANTICOAGULANT REVERSAL DRUGS MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET
TABLE 3. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 20. U.S. ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 21. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW ANTICOAGULANT REVERSAL DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)